Literature DB >> 31625659

The Core Fucose on an IgG Antibody is an Endogenous Ligand of Dectin-1.

Yoshiyuki Manabe1,2, Roberta Marchetti3, Yohei Takakura1, Masahiro Nagasaki1, Wataru Nihei1, Tomoyuki Takebe1, Katsunori Tanaka1,4, Kazuya Kabayama1,2, Fabrizio Chiodo5, Shinya Hanashima1, Yoshihiro Kamada6, Eiji Miyoshi6, Hari Prasad Dulal7, Yoshiki Yamaguchi8, Yoshiyuki Adachi9, Naohito Ohno9, Hiroshi Tanaka10, Alba Silipo3, Koichi Fukase1,2, Antonio Molinaro1,3.   

Abstract

The core fucose, a major modification of N-glycans, is implicated in immune regulation, such as the attenuation of the antibody-dependent cell-mediated cytotoxicity of antibody drugs and the inhibition of anti-tumor responses via the promotion of PD-1 expression on T cells. Although the core fucose regulates many biological processes, no core fucose recognition molecule has been identified in mammals. Herein, we report that Dectin-1, a known anti-β-glucan lectin, recognizes the core fucose on IgG antibodies. A combination of biophysical experiments further suggested that Dectin-1 recognizes aromatic amino acids adjacent to the N-terminal asparagine at the glycosylation site as well as the core fucose. Thus, Dectin-1 appears to be the first lectin-like molecule involved in the heterovalent and specific recognition of characteristic N-glycans on antibodies.
© 2019 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Dectin-1; IgG; N-glycan; fucose; molecular recognition

Year:  2019        PMID: 31625659     DOI: 10.1002/anie.201911875

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   15.336


  15 in total

Review 1.  Emerging roles of Dectin-1 in noninfectious settings and in the CNS.

Authors:  M Elizabeth Deerhake; Mari L Shinohara
Journal:  Trends Immunol       Date:  2021-09-04       Impact factor: 19.709

Review 2.  What is the Sugar Code?

Authors:  Hans-Joachim Gabius; Maré Cudic; Tammo Diercks; Herbert Kaltner; Jürgen Kopitz; Kevin H Mayo; Paul V Murphy; Stefan Oscarson; René Roy; Andreas Schedlbauer; Stefan Toegel; Antonio Romero
Journal:  Chembiochem       Date:  2021-09-22       Impact factor: 3.461

3.  Characterizing human α-1,6-fucosyltransferase (FUT8) substrate specificity and structural similarities with related fucosyltransferases.

Authors:  Bhargavi M Boruah; Renuka Kadirvelraj; Lin Liu; Annapoorani Ramiah; Chao Li; Guanghui Zong; Gerlof P Bosman; Jeong-Yeh Yang; Lai-Xi Wang; Geert-Jan Boons; Zachary A Wood; Kelley W Moremen
Journal:  J Biol Chem       Date:  2020-10-01       Impact factor: 5.157

4.  Structural basis of substrate recognition and catalysis by fucosyltransferase 8.

Authors:  Michael A Järvå; Marija Dramicanin; James P Lingford; Runyu Mao; Alan John; Kate E Jarman; Rhys Grinter; Ethan D Goddard-Borger
Journal:  J Biol Chem       Date:  2020-03-27       Impact factor: 5.157

Review 5.  Antibody glycosylation in autoimmune diseases.

Authors:  Xing Zhou; Francesca Motta; Carlo Selmi; William M Ridgway; M Eric Gershwin; Weici Zhang
Journal:  Autoimmun Rev       Date:  2021-03-14       Impact factor: 9.754

Review 6.  Impact of Plasma Membrane Domains on IgG Fc Receptor Function.

Authors:  Sibel Kara; Lukas Amon; Jennifer J Lühr; Falk Nimmerjahn; Diana Dudziak; Anja Lux
Journal:  Front Immunol       Date:  2020-06-30       Impact factor: 7.561

Review 7.  Recent Advances in the Chemical Biology of N-Glycans.

Authors:  Asuka Shirakawa; Yoshiyuki Manabe; Koichi Fukase
Journal:  Molecules       Date:  2021-02-16       Impact factor: 4.411

Review 8.  3D Structural Insights into β-Glucans and Their Binding Proteins.

Authors:  Noriyoshi Manabe; Yoshiki Yamaguchi
Journal:  Int J Mol Sci       Date:  2021-02-04       Impact factor: 5.923

9.  Aptamers targeting protein-specific glycosylation in tumor biomarkers: general selection, characterization and structural modeling.

Authors:  Ana Díaz-Fernández; Rebeca Miranda-Castro; Natalia Díaz; Dimas Suárez; Noemí de-Los-Santos-Álvarez; M Jesús Lobo-Castañón
Journal:  Chem Sci       Date:  2020-07-21       Impact factor: 9.825

Review 10.  Keratan sulfate-based glycomimetics using Langerin as a target for COPD: lessons from studies on Fut8 and core fucose.

Authors:  Yuki Ohkawa; Yoichiro Harada; Naoyuki Taniguchi
Journal:  Biochem Soc Trans       Date:  2021-02-26       Impact factor: 5.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.